Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

KARS anticorps (AA 101-400)

KARS Reactivité: Humain WB, ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7158683
  • Antigène Voir toutes KARS Anticorps
    KARS (Lysyl-tRNA Synthetase (KARS))
    Épitope
    • 15
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 101-400
    Reactivité
    • 45
    • 15
    • 12
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 44
    • 2
    Lapin
    Clonalité
    • 36
    • 11
    Polyclonal
    Conjugué
    • 22
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp KARS est non-conjugé
    Application
    • 34
    • 14
    • 13
    • 11
    • 9
    • 7
    • 5
    • 4
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Lysine--tRNA ligase protein (101-400AA)
    Isotype
    IgG
    Top Product
    Discover our top product KARS Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    KARS (Lysyl-tRNA Synthetase (KARS))
    Autre désignation
    KARS (KARS Produits)
    Synonymes
    anticorps CG12141, anticorps Dmel\\CG12141, anticorps KRS, anticorps LysRS, anticorps cb530, anticorps wu:fa16h02, anticorps zgc:92483, anticorps kars, anticorps MGC53345, anticorps kars2, anticorps krs, anticorps krs-1, anticorps KARS, anticorps Tb06.28P18.190, anticorps CMTRIB, anticorps DFNB89, anticorps KARS1, anticorps KARS2, anticorps AA589550, anticorps AL024334, anticorps AL033315, anticorps AL033367, anticorps D8Ertd698e, anticorps D8Wsu108e, anticorps mKIAA0070, anticorps Lysyl-tRNA synthetase, anticorps lysyl-tRNA synthetase, anticorps lysyl-tRNA synthetase S homeolog, anticorps lysyl-tRNA synthetase L homeolog, anticorps LysRS, anticorps kars, anticorps kars.S, anticorps kars.L, anticorps Bm1_16500, anticorps lysS, anticorps Taci_1118, anticorps Tpau_1737, anticorps Arch_0261, anticorps Trad_2960, anticorps Spirs_3699, anticorps KARS, anticorps LOC100280510, anticorps Tb927.6.1510, anticorps Kars
    Sujet

    Background: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA (PubMed:9278442, PubMed:18029264, PubMed:18272479). When secreted, acts as a signaling molecule that induces immune response through the activation of monocyte/macrophages (PubMed:15851690). Catalyzes the synthesis of the signaling molecule diadenosine tetraphosphate (Ap4A), and thereby mediates disruption of the complex between HINT1 and MITF and the concomitant activation of MITF transcriptional activity (PubMed:5338216, PubMed:14975237, PubMed:19524539, PubMed:23159739). (Microbial infection) Interacts with HIV-1 virus GAG protein, facilitating the selective packaging of tRNA3(Lys), the primer for reverse transcription initiation.

    Aliases: CMTRIB antibody, DFNB89 antibody, EC 6.1.1.6 antibody, KARS 1 antibody, KARS 2 antibody, KARS antibody, KARS1 antibody, KARS2 antibody, KIAA0070 antibody, KRS antibody, Lysine tRNA ligase antibody, Lysine--tRNA ligase antibody, LysRS antibody, Lysyl tRNA synthetase antibody, Lysyl-tRNA synthetase antibody, SYK_HUMAN antibody

    UniProt
    Q15046
Vous êtes ici: